{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:22:26Z","timestamp":1747207346424,"version":"3.40.5"},"reference-count":112,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDDT"],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Schistosome infection is regarded as one of the most important and neglected tropical\ndiseases associated with poor sanitation. Like other living organisms, schistosomes employ multiple\nbiological processes, of which some are regulated by a post-translational modification called\nAdenosine Diphosphate-ribosylation (ADP-ribosylation), catalyzed by ADP-ribosyltransferases.\nADP-ribosylation is the addition of ADP-ribose moieties from Nicotinamide Adenine Dinucleotide\n(NAD+) to various targets, which include proteins and nucleotides. It is crucial in biological\nprocesses such as DNA repair, apoptosis, carbohydrate metabolism and catabolism. In the absence\nof a vaccine against schistosomiasis, this becomes a promising pathway in the identification\nof drug targets against various forms of this infection. The tegument of the worm is an encouraging\nimmunogenic target for anti-schistosomal vaccine development. Vaccinology, molecular\nmodeling and target-based drug discovery strategies have been used for years in drug discovery\nand for vaccine development. In this paper, we outline ADP-ribosylation and other different\napproaches to drug discovery and vaccine development against schistosomiasis.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1570163817666200806170654","type":"journal-article","created":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T06:25:38Z","timestamp":1596867938000},"page":"473-482","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular Context of ADP-ribosylation in Schistosomes for Drug Discovery and Vaccine Development"],"prefix":"10.2174","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5312-9428","authenticated-orcid":true,"given":"Amandla","family":"Chutshela","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Microbiology, University of Zululand, KwaDlangezwa 3886,South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1329-1057","authenticated-orcid":true,"given":"Priscilla","family":"Masamba","sequence":"additional","affiliation":[{"name":"Molecular Biophysics and Structural Biology Group, Department of Biochemistry, University of Johannesburg, Kingsway Campus, Auckland Park 2006,South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2165-7936","authenticated-orcid":true,"given":"Babatunji Emmanuel","family":"Oyinloye","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Microbiology, University of Zululand, KwaDlangezwa 3886,South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2521-8957","authenticated-orcid":true,"given":"Abidemi Paul","family":"Kappo","sequence":"additional","affiliation":[{"name":"Molecular Biophysics and Structural Biology Group, Department of Biochemistry, University of Johannesburg, Kingsway Campus, Auckland Park 2006,South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"4163","DOI":"10.1073\/pnas.1302537110","volume":"110","author":"Jank T.","year":"2013","unstructured":"Jank T.; Aktories K.; Strain-alleviation model of ADP-ribosylation. Proc Natl Acad Sci USA 2013,110(11),4163-4164","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1146\/annurev.bi.54.070185.000445","volume":"54","author":"Ueda K.","year":"1985","unstructured":"Ueda K.; Hayaishi O.; ADP-ribosylation. Annu Rev Biochem 1985,54(1),73-100","journal-title":"Annu Rev Biochem"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/B978-0-12-375709-8.00003-4","author":"Herceg Z.","year":"2011","unstructured":"Herceg Z.; Murr R.;  Mechanisms of histone modifications Handbook of Epigenetics 2011,25-45","journal-title":"Mechanisms of histone modifications Handbook of Epigenetics"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"491","DOI":"10.2174\/1389203716666150504122435","volume":"16","author":"Liu C.","year":"2015","unstructured":"Liu C.; Yu X.; ADP-ribosyltransferases and poly ADP-ribosylation. Curr Protein Pept Sci 2015,16(6),491-501","journal-title":"Curr Protein Pept Sci"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biom3010001","volume":"3","author":"\u017daja R.","year":"2012","unstructured":"\u017daja R.; Miko\u010d A.; Barkauskaite E.; Ahel I.; Molecular insights into poly (ADP-ribose) recognition and processing. Biomolecules 2012,3(1),1-17","journal-title":"Biomolecules"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"12872","DOI":"10.1016\/S0021-9258(18)33596-8","volume":"257","author":"Wielckens K.","year":"1982","unstructured":"Wielckens K.; Schmidt A.; George E.; Bredehorst R.; Hilz H.; DNA fragmentation and NAD depletion. Their relation to the turnover of endogenous mono(ADP-ribosyl) and poly(ADP-ribosyl) proteins. J Biol Chem 1982,257(21),12872-12877","journal-title":"J Biol Chem"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"4579","DOI":"10.1111\/j.1742-4658.2006.05442.x","volume":"273","author":"Holbourn K.P.","year":"2006","unstructured":"Holbourn K.P.; Shone C.C.; Acharya K.R.; A family of killer toxins. Exploring the mechanism of ADP-ribosylating toxins. FEBS J 2006,273(20),4579-4593","journal-title":"FEBS J"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/1471-2164-6-139","volume":"6","author":"Otto H.","year":"2005","unstructured":"Otto H.; Reche P.A.; Bazan F.; Dittmar K.; Haag F.; Koch-Nolte F.; In silico characterization of the family of PARP-like poly(ADP-ribosyl)transferases (pARTs). BMC Genomics 2005,6(1),139","journal-title":"BMC Genomics"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.tibs.2005.12.007","volume":"31","author":"Yates S.P.","year":"2006","unstructured":"Yates S.P.; J\u00f8rgensen R.; Andersen G.R.; Merrill A.R.; Stealth and mimicry by deadly bacterial toxins. Trends Biochem Sci 2006,31(2),123-133","journal-title":"Trends Biochem Sci"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"4267","DOI":"10.1073\/pnas.1217227110","volume":"110","author":"Tsurumura T.","year":"2013","unstructured":"Tsurumura T.; Tsumori Y.; Qiu H.; Arginine ADP-ribosylation mechanism based on structural snapshots of iota-toxin and actin complex. Proc Natl Acad Sci USA 2013,110(11),4267-4272","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.tibs.2008.08.003","volume":"33","author":"Fieldhouse R.J.","year":"2008","unstructured":"Fieldhouse R.J.; Merrill A.R.; Needle in the haystack: structure-based toxin discovery. Trends Biochem Sci 2008,33(11),546-556","journal-title":"Trends Biochem Sci"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1126\/science.1184557","volume":"327","author":"Lang A.E.","year":"2010","unstructured":"Lang A.E.; Schmidt G.; Schlosser A.; Photorhabdus luminescens toxins ADP-ribosylate actin and RhoA to force actin clustering. Science 2010,327(5969),1139-1142","journal-title":"Science"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0166-6851(88)90133-8","volume":"30","author":"Estey S.J.","year":"1988","unstructured":"Estey S.J.; Mansour T.E.; GTP binding regulatory proteins of adenylate cyclase in Schistosoma mansoni at different stages of development. Mol Biochem Parasitol 1988,30(1),67-75","journal-title":"Mol Biochem Parasitol"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1016\/S0021-9258(17)43131-0","volume":"259","author":"Bokoch G.M.","year":"1984","unstructured":"Bokoch G.M.; Katada T.; Northup J.K.; Ui M.; Gilman A.G.; Purification and properties of the inhibitory guanine nucleotide-binding regulatory component of adenylate cyclase. J Biol Chem 1984,259(6),3560-3567","journal-title":"J Biol Chem"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1016\/S0021-9258(18)34843-9","volume":"257","author":"Katada T.","year":"1982","unstructured":"Katada T.; Amano T.; Ui M.; Modulation by islet-activating protein of adenylate cyclase activity in C6 glioma cells. J Biol Chem 1982,257(7),3739-3746","journal-title":"J Biol Chem"},{"key":"ref=16","author":"Pamu S.","year":"2018","unstructured":"Pamu S.; Singh T.; Chandrudu J.;  Schistosoma and Human Schistosomiasis 2018","journal-title":"Schistosoma and Human Schistosomiasis"},{"key":"ref=17","author":"Doughty B.L.","year":"1996","unstructured":"Doughty B.L.;  Schistosomes and other trematodesMedical microbiology 1996","journal-title":"Schistosomes and other trematodesMedical microbiology"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1073\/pnas.75.6.2669","volume":"75","author":"Cassel D.","year":"1978","unstructured":"Cassel D.; Pfeuffer T.; Mechanism of cholera toxin action: Covalent modification of the guanyl nucleotide-binding protein of the adenylate cyclase system. Proc Natl Acad Sci USA 1978,75(6),2669-2673","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/nature03443","volume":"434","author":"Bryant H.E.","year":"2005","unstructured":"Bryant H.E.; Schultz N.; Thomas H.D.; Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 2005,434(7035),913-917","journal-title":"Nature"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nature03445","volume":"434","author":"Farmer H.","year":"2005","unstructured":"Farmer H.; McCabe N.; Lord C.J.; Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 2005,434(7035),917-921","journal-title":"Nature"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1056\/NEJMoa0900212","volume":"361","author":"Fong P.C.","year":"2009","unstructured":"Fong P.C.; Boss D.S.; Yap T.A.; Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med 2009,361(2),123-134","journal-title":"N Engl J Med"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"5327","DOI":"10.1158\/0008-5472.CAN-10-0733","volume":"71","author":"Kato J.","year":"2011","unstructured":"Kato J.; Zhu J.; Liu C.; ADP-ribosylarginine hydrolase regulates cell proliferation and tumorigenesis. Cancer Res 2011,71(15),5327-5335","journal-title":"Cancer Res"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1128\/CMR.8.1.34","volume":"8","author":"Krueger K.M.","year":"1995","unstructured":"Krueger K.M.; Barbieri J.T.; The family of bacterial ADP-ribosylating exotoxins. Clin Microbiol Rev 1995,8(1),34-47","journal-title":"Clin Microbiol Rev"},{"key":"ref=24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002428","volume":"7","author":"Lancelot J.","year":"2013","unstructured":"Lancelot J.; Caby S.; Dubois-Abdesselem F.; Schistosoma mansoni Sirtuins: Characterization and potential as chemotherapeutic targets. PLoS Negl Trop Dis 2013,7(9)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nrd3674","volume":"11","author":"Arrowsmith C.H.","year":"2012","unstructured":"Arrowsmith C.H.; Bountra C.; Fish P.V.; Lee K.; Schapira M.; Epigenetic protein families: A new frontier for drug discovery. Nat Rev Drug Discov 2012,11(5),384-400","journal-title":"Nat Rev Drug Discov"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"653","DOI":"10.7326\/0003-4819-101-5-653","volume":"101","author":"Moss J.","year":"1984","unstructured":"Moss J.; Burns D.L.; Hsia J.A.; Hewlett E.L.; Guerrant R.L.; Vaughan M.; NIH conference. Cyclic nucleotides: Mediators of bacterial toxin action in disease. Ann Intern Med 1984,101(5),653-666","journal-title":"Ann Intern Med"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1186\/1471-2164-13-S1-S4","volume":"13","author":"Lee H.","year":"2012","unstructured":"Lee H.; Moody-Davis A.; Saha U.; Quantification and clustering of phenotypic screening data using time-series analysis for chemotherapy of schistosomiasis. BMC Genomics 2012,13(1)(Suppl. 1),S4","journal-title":"BMC Genomics"},{"key":"ref=28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151861","volume":"11","author":"Stanley R.J.","year":"2016","unstructured":"Stanley R.J.; Thomas G.M.; Activation of G proteins by guanine nucleotide exchange factors relies on GTPase activity. PLoS One 2016,11(3)","journal-title":"PLoS One"},{"key":"ref=29","first-page":"131","author":"Itoh H","year":"1993","unstructured":"Itoh H; Kaziro Y.; Heterotrimeric G-Proteins: \u03b1, \u03b2, and \u03b3 Subunits GTPases in Biology. 1993,131-149"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1159\/000186689","volume":"17","author":"Mizuno N.","year":"2009","unstructured":"Mizuno N.; Itoh H.; Functions and regulatory mechanisms of Gq-signaling pathways. Neurosignals 2009,17(1),42-54","journal-title":"Neurosignals"},{"key":"ref=31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000804","volume":"4","author":"Crowther G.J.","year":"2010","unstructured":"Crowther G.J.; Shanmugam D.; Carmona S.J.; Identification of attractive drug targets in neglected-disease pathogens using an in silico approach. PLoS Negl Trop Dis 2010,4(8)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1186\/1471-2164-12-596","volume":"12","author":"Zamanian M.","year":"2011","unstructured":"Zamanian M.; Kimber M.J.; McVeigh P.; Carlson S.A.; Maule A.G.; Day T.A.; The repertoire of G protein-coupled receptors in the human parasite Schistosoma mansoni and the model organism Schmidtea mediterranea. BMC Genomics 2011,12(1),596","journal-title":"BMC Genomics"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0166-6851(82)90045-7","volume":"5","author":"Kasschau M.R.","year":"1982","unstructured":"Kasschau M.R.; Mansour T.E.; Adenylate cyclase in adults and cercariae of Schistosoma mansoni. Mol Biochem Parasitol 1982,5(2),107-116","journal-title":"Mol Biochem Parasitol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/j.1476-5381.1966.tb01845.x","volume":"26","author":"Barker L.R.","year":"1966","unstructured":"Barker L.R.; Bueding E.; Timms A.R.; The possible role of acetylcholine in Schistosoma mansoni. Br J Pharmacol Chemother 1966,26(3),656-665","journal-title":"Br J Pharmacol Chemother"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1073\/pnas.74.8.3307","volume":"74","author":"Cassel D.","year":"1977","unstructured":"Cassel D.; Selinger Z.; Mechanism of adenylate cyclase activation by cholera toxin: inhibition of GTP hydrolysis at the regulatory site. Proc Natl Acad Sci USA 1977,74(8),3307-3311","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003878","volume":"10","author":"Patocka N.","year":"2014","unstructured":"Patocka N.; Sharma N.; Rashid M.; Ribeiro P.; Serotonin signaling in Schistosoma mansoni: a serotonin-activated G protein-coupled receptor controls parasite movement. PLoS Pathog 2014,10(1)","journal-title":"PLoS Pathog"},{"key":"ref=37","author":"Mbah A.N.","year":"2012","unstructured":"Mbah A.N.; Kamga H.L.; Awofolu O.R.; Isokpehi R.D.; rug target exploitable structural features of adenylyl cyclase activity in Schistosoma mansoni. Drug Target Insights 2012","journal-title":"Drug Target Insights"},{"key":"ref=38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000505","volume":"3","author":"Swierczewski B.E.","year":"2009","unstructured":"Swierczewski B.E.; Davies S.J.; A schistosome cAMP-dependent protein kinase catalytic subunit is essential for parasite viability. PLoS Negl Trop Dis 2009,3(8)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0001-706X(02)00045-1","volume":"82","author":"Engels D.","year":"2002","unstructured":"Engels D.; Chitsulo L.; Montresor A.; Savioli L.; The global epidemiological situation of schistosomiasis and new approaches to control and research. Acta Trop 2002,82(2),139-146","journal-title":"Acta Trop"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/356604a0","volume":"356","author":"Amiri P.","year":"1992","unstructured":"Amiri P.; Locksley R.M.; Parslow T.G.; Tumour necrosis factor \u03b1 restores granulomas and induces parasite egg-laying in schistosome-infected SCID mice. Nature 1992,356(6370),604-607","journal-title":"Nature"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1126\/science.1064462","volume":"294","author":"Davies S.J.","year":"2001","unstructured":"Davies S.J.; Grogan J.L.; Blank R.B.; Lim K.C.; Locksley R.M.; McKerrow J.H.; Modulation of blood fluke development in the liver by hepatic CD4+ lymphocytes. Science 2001,294(5545),1358-1361","journal-title":"Science"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1645\/00223395(2002)088[0849:EVOHTA]2.0.CO;2","volume":"88","author":"Saule P","year":"2002","unstructured":"Saule P; Adriaenssens E; Delacre M; Early variations of host thyroxine and interleukin-7 favor Schistosoma mansoni development. J Parasitol 2002,88(5),849-855","journal-title":"J Parasitol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"4183","DOI":"10.1128\/IAI.67.8.4183-4190.1999","volume":"67","author":"Wolowczuk I.","year":"1999","unstructured":"Wolowczuk I.; Nutten S.; Roye O.; Infection of mice lacking interleukin-7 (IL-7) reveals an unexpected role for IL-7 in the development of the parasite Schistosoma mansoni. Infect Immun 1999,67(8),4183-4190","journal-title":"Infect Immun"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0021-9258(19)86022-2","volume":"255","author":"Enomoto K.","year":"1980","unstructured":"Enomoto K.; Gill D.M.; Cholera toxin activation of adenylate cyclase. Roles of nucleoside triphosphates and a macromolecular factor in the ADP ribosylation of the GTP-dependent regulatory component. J Biol Chem 1980,255(4),1252-1258","journal-title":"J Biol Chem"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.bj.2016.06.006","volume":"39","author":"Silva C.L.M.","year":"2016","unstructured":"Silva C.L.M.; Purinergic signaling in schistosomal infection. Biomed J 2016,39(5),316-325","journal-title":"Biomed J"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0014-5793(97)01410-5","volume":"418","author":"Higashida H.","year":"1997","unstructured":"Higashida H.; ADP-ribosyl cyclase coupled with receptors via G proteins. FEBS Lett 1997,418(3),355-356","journal-title":"FEBS Lett"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"986","DOI":"10.2741\/4262","volume":"19","author":"Ferrero E.","year":"2014","unstructured":"Ferrero E.; Lo Buono N.; Horenstein A.L.; Funaro A.; Malavasi F.; The ADP-ribosyl cyclases--The current evolutionary state of the ARCs. Front Biosci 2014,19,986-1002","journal-title":"Front Biosci"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"3218","DOI":"10.1021\/bi00385a042","volume":"26","author":"Alvarez-Gonzalez R.","year":"1987","unstructured":"Alvarez-Gonzalez R.; Jacobson M.K.; Characterization of polymers of adenosine diphosphate ribose generated in vitro and in vivo. Biochemistry 1987,26(11),3218-3224","journal-title":"Biochemistry"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/nature10404","volume":"477","author":"Slade D.","year":"2011","unstructured":"Slade D.; Dunstan M.S.; Barkauskaite E.; The structure and catalytic mechanism of a poly(ADP-ribose) glycohydrolase. Nature 2011,477(7366),616-620","journal-title":"Nature"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"5045","DOI":"10.1093\/nar\/gkr099","volume":"39","author":"Mortusewicz O.","year":"2011","unstructured":"Mortusewicz O.; Fouquerel E.; Am\u00e9 J-C.; Leonhardt H.; Schreiber V.; PARG is recruited to DNA damage sites through poly(ADP-ribose)- and PCNA-dependent mechanisms. Nucleic Acids Res 2011,39(12),5045-5056","journal-title":"Nucleic Acids Res"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"942","DOI":"10.4161\/psb.4.10.9530","volume":"4","author":"Tuteja N.","year":"2009","unstructured":"Tuteja N.; Signaling through G protein coupled receptors. Plant Signal Behav 2009,4(10),942-947","journal-title":"Plant Signal Behav"},{"key":"ref=52","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a005926","volume":"8","author":"Newton A.C.","year":"2016","unstructured":"Newton A.C.; Bootman M.D.; Scott J.D.; Second Messengers. Cold Spring Harb Perspect Biol 2016,8(8)","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1161\/01.RES.0000247760.34779.f5","volume":"99","author":"Bornfeldt K.E.","year":"2006","unstructured":"Bornfeldt K.E.; A single second messenger: Several possible cellular responses depending on distinct subcellular pools. Circ Res 2006,99(8),790-792","journal-title":"Circ Res"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3390\/cancers6010436","volume":"6","author":"Fajardo A.M.","year":"2014","unstructured":"Fajardo A.M.; Piazza G.A.; Tinsley H.N.; The role of cyclic nucleotide signaling pathways in cancer: targets for prevention and treatment. Cancers (Basel) 2014,6(1),436-458","journal-title":"Cancers (Basel)"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/j.1745-7270.2008.00438.x","volume":"40","author":"Cheng X.","year":"2008","unstructured":"Cheng X.; Ji Z.; Tsalkova T.; Mei F.; Epac and PKA: a tale of two intracellular cAMP receptors. Acta Biochim Biophys Sin (Shanghai) 2008,40(7),651-662","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nrm3072","volume":"12","author":"Altarejos J.Y.","year":"2011","unstructured":"Altarejos J.Y.; Montminy M.; CREB and the CRTC co-activators: sensors for hormonal and metabolic signals. Nat Rev Mol Cell Biol 2011,12(3),141-151","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=57","first-page":"223","volume":"56","author":"Borba-Murad G.R.","year":"2004","unstructured":"Borba-Murad G.R.; Vardanega-Peicher M.; Galende S.B.; Central role of cAMP in the inhibition of glycogen breakdown and gluconeogenesis promoted by leptin and insulin in perfused rat liver. Pol J Pharmacol 2004,56(2),223-231","journal-title":"Pol J Pharmacol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1046\/j.1469-8137.1997.00798.x","volume":"137","author":"Hoffmann E.","year":"1997","unstructured":"Hoffmann E.; Wallenda T.; Schaeffer C.; Hampp R.; Cyclic AMP, a possible regulator of glycolysis in the ectomycorrhizal fungus Amanita muscaria. New Phytol 1997,137(2),351-356","journal-title":"New Phytol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1042\/BJ20040752","volume":"381","author":"Rider M.H.","year":"2004","unstructured":"Rider M.H.; Bertrand L.; Vertommen D.; Michels P.A.; Rousseau G.G.; Hue L.; 6-phosphofructo-2-kinase\/fructose-2,6-bisphosphatase: head-to-head with a bifunctional enzyme that controls glycolysis. Biochem J 2004,381(Pt 3),561-579","journal-title":"Biochem J"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nrm2082","volume":"8","author":"Rehmann H.","year":"2007","unstructured":"Rehmann H.; Wittinghofer A.; Bos J.L.; Capturing cyclic nucleotides in action: snapshots from crystallographic studies. Nat Rev Mol Cell Biol 2007,8(1),63-73","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.pharmthera.2013.06.001","volume":"140","author":"Pfeifer A.","year":"2013","unstructured":"Pfeifer A.; Kili\u0107 A.; Hoffmann L.S.; Regulation of metabolism by cGMP. Pharmacol Ther 2013,140(1),81-91","journal-title":"Pharmacol Ther"},{"key":"ref=62","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00704.2012","author":"Moro C.","year":"2013","unstructured":"Moro C.; Lafontan M.; Drug target exploitable structural features of adenylyl cyclase activity in Schistosoma mansoni. Drug Target Insights 2013","journal-title":"Drug Target Insights"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/wsbm.1223","volume":"5","author":"Arshad N.","year":"2013","unstructured":"Arshad N.; Visweswariah S.S.; Cyclic nucleotide signaling in intestinal epithelia: getting to the gut of the matter. Wiley Interdiscip Rev Syst Biol Med 2013,5(4),409-424","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/s41598-018-19619-0","volume":"8","author":"Cou\u00e9 M.","year":"2018","unstructured":"Cou\u00e9 M.; Barquissau V.; Morigny P.; Natriuretic peptides promote glucose uptake in a cGMP-dependent manner in human adipocytes. Sci Rep 2018,8(1),1097","journal-title":"Sci Rep"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3945\/an.112.002089","volume":"3","author":"Moore M.C.","year":"2012","unstructured":"Moore M.C.; Coate K.C.; Winnick J.J.; An Z.; Cherrington A.D.; Regulation of hepatic glucose uptake and storage in vivo. Adv Nutr 2012,3(3),286-294","journal-title":"Adv Nutr"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.pt.2009.03.004","volume":"25","author":"Bhardwaj R.","year":"2009","unstructured":"Bhardwaj R.; Skelly P.J.; Purinergic signaling and immune modulation at the schistosome surface? Trends Parasitol 2009,25(6),256-260","journal-title":"Trends Parasitol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s11302-014-9416-5","volume":"10","author":"Da\u2019dara A.A.","year":"2014","unstructured":"Da\u2019dara A.A.; Bhardwaj R.; Skelly P.J.; Schistosome apyrase SmATPDase1, but not SmATPDase2, hydrolyses exogenous ATP and ADP. Purinergic Signal 2014,10(4),573-580","journal-title":"Purinergic Signal"},{"key":"ref=68","author":"Cooper J.","year":"2011","unstructured":"Cooper J.;  Second Messenger 2011 https:\/\/www.britannica.com\/science\/second-messenger","journal-title":"Second Messenger"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.pharmthera.2009.02.009","volume":"122","author":"Tsai E.J.","year":"2009","unstructured":"Tsai E.J.; Kass D.A.; Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics. Pharmacol Ther 2009,122(3),216-238","journal-title":"Pharmacol Ther"},{"year":"2012","author":"Klabunde R.","unstructured":"Klabunde R.; General Pharmacology of cAMP-Dependent Phosphodiesterase Inhibitors (PDE3) 2012 https:\/\/cvpharmacology.com\/vasodilator\/PDEI","key":"ref=70"},{"key":"ref=71","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006023","volume":"7","author":"Kuo I.Y.","year":"2015","unstructured":"Kuo I.Y.; Ehrlich B.E.; Signaling in muscle contraction. Cold Spring Harb Perspect Biol 2015,7(2)","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.3390\/ph3041016","volume":"3","author":"Barisione G.","year":"2010","unstructured":"Barisione G.; Baroffio M.; Crimi E.; Brusasco V.; Beta-Adrenergic Agonists. Pharmaceuticals (Basel) 2010,3(4),1016-1044","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref=73","doi-asserted-by":"publisher","DOI":"10.5005\/jp\/books\/12078","author":"Kapoor A.","year":"2013","unstructured":"Kapoor A.; Raju S.;  Illustrated medical pharmacology 2013","journal-title":"Illustrated medical pharmacology"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"20975","DOI":"10.1074\/jbc.M112.341479","volume":"287","author":"Khromov A.S.","year":"2012","unstructured":"Khromov A.S.; Momotani K.; Jin L.; Molecular mechanism of telokin-mediated disinhibition of myosin light chain phosphatase and cAMP\/cGMP-induced relaxation of gastrointestinal smooth muscle. J Biol Chem 2012,287(25),20975-20985","journal-title":"J Biol Chem"},{"key":"ref=75","first-page":"407","volume":"38","author":"Huang S.A.","year":"2013","unstructured":"Huang S.A.; Lie J.D.; Phosphodiesterase-5 (PDE5) inhibitors in the management of erectile dysfunction. P 2013,38(7),407-419","journal-title":"P"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1128\/MCB.21.11.3671-3683.2001","volume":"21","author":"Schmitt J.M.","year":"2001","unstructured":"Schmitt J.M.; Stork P.J.; Cyclic AMP-mediated inhibition of cell growth requires the small G protein Rap1. Mol Cell Biol 2001,21(11),3671-3683","journal-title":"Mol Cell Biol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1152\/physrev.1976.56.4.652","volume":"56","author":"Friedman D.L.","year":"1976","unstructured":"Friedman D.L.; Role of cyclic nucleotides in cell growth and differentiation. Physiol Rev 1976,56(4),652-708","journal-title":"Physiol Rev"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/jcp.1040820207","volume":"82","author":"Vogel A.","year":"1973","unstructured":"Vogel A.; Pollack R.; Isolation and characterization of revertant cell lines. IV. Direct selection of serum-revertant sublines of SV40-transformed 3T3 mouse cells. J Cell Physiol 1973,82(2),189-198","journal-title":"J Cell Physiol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1182\/blood-2009-02-204883","volume":"114","author":"Naderi E.H.","year":"2009","unstructured":"Naderi E.H.; Findley H.W.; Ruud E.; Blomhoff H.K.; Naderi S.; Activation of cAMP signaling inhibits DNA damage-induced apoptosis in BCP-ALL cells through abrogation of p53 accumulation. Blood 2009,114(3),608-618","journal-title":"Blood"},{"key":"ref=80","author":"Christopher R.","year":"2016","unstructured":"Christopher R.;  Drug addiction 2016 https:\/\/streetdrugs.org\/drug-addiction\/","journal-title":"Drug addiction"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3390\/metabo2020303","volume":"2","author":"Dias D.A.","year":"2012","unstructured":"Dias D.A.; Urban S.; Roessner U.; A historical overview of natural products in drug discovery. Metabolites 2012,2(2),303-336","journal-title":"Metabolites"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1001\/jama.2009.506","volume":"301","author":"Kiser A.K.","year":"2009","unstructured":"Kiser A.K.; Pronovost P.J.; Management of diseases without current treatment options: something can be done. JAMA 2009,301(16),1708-1709","journal-title":"JAMA"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.2174\/1568026614666140929124445","volume":"14","author":"Lionta E.","year":"2014","unstructured":"Lionta E.; Spyrou G.; Vassilatis D.K.; Cournia Z.; Structure-based virtual screening for drug discovery: principles, applications and recent advances. Curr Top Med Chem 2014,14(16),1923-1938","journal-title":"Curr Top Med Chem"},{"key":"ref=84","author":"Kenakin T.","year":"2018","unstructured":"Kenakin T.;  A pharmacology primer: techniques for more effective and strategic drug discovery 2018","journal-title":"A pharmacology primer: techniques for more effective and strategic drug discovery"},{"key":"ref=85","doi-asserted-by":"publisher","DOI":"10.4172\/jaa.1000025","volume":"2","author":"Prakash N.","year":"2010","unstructured":"Prakash N.; Devangi P.; Drug Discovery. J Antivir Antiretrovir 2010,2(4)","journal-title":"J Antivir Antiretrovir"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"624","DOI":"10.2174\/138161213804581882","volume":"19","author":"Dani N.","year":"2013","unstructured":"Dani N.; Barbosa A.J.; Del Rio A.; Di Girolamo M.; ADP-ribosylated proteins as old and new drug targets for anticancer therapy: the example of ARF6. Curr Pharm Des 2013,19(4),624-633","journal-title":"Curr Pharm Des"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.chembiol.2016.08.012","volume":"23","author":"Venkannagari H.","year":"2016","unstructured":"Venkannagari H.; Verheugd P.; Koivunen J.; Small-molecule chemical probe rescues cells from mono-ADP-ribosyltransferase ARTD10\/PARP10-induced apoptosis and sensitizes cancer cells to DNA damage. Cell Chem Biol 2016,23(10),1251-1260","journal-title":"Cell Chem Biol"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1016\/j.bmcl.2018.04.056","volume":"28","author":"Holechek J.","year":"2018","unstructured":"Holechek J.; Lease R.; Thorsell A-G.; Design, synthesis and evaluation of potent and selective inhibitors of mono-(ADP-ribosyl)transferases PARP10 and PARP14. Bioorg Med Chem Lett 2018,28(11),2050-2054","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ejmech.2018.06.047","volume":"156","author":"Murthy S.","year":"2018","unstructured":"Murthy S.; Desantis J.; Verheugd P.; 4-(Phenoxy) and 4-(benzyloxy)benzamides as potent and selective inhibitors of mono-ADP-ribosyltransferase PARP10\/ARTD10. Eur J Med Chem 2018,156,93-102","journal-title":"Eur J Med Chem"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nrd1718","volume":"4","author":"Jagtap P.","year":"2005","unstructured":"Jagtap P.; Szab\u00f3 C.; Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat Rev Drug Discov 2005,4(5),421-440","journal-title":"Nat Rev Drug Discov"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1111\/bcp.12468","volume":"78","author":"Beaumont C.","year":"2014","unstructured":"Beaumont C.; Young G.C.; Cavalier T.; Young M.A.; Human absorption, distribution, metabolism and excretion properties of drug molecules: a plethora of approaches. Br J Clin Pharmacol 2014,78(6),1185-1200","journal-title":"Br J Clin Pharmacol"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/S1359-6446(03)02902-7","volume":"8","author":"Brown D.","year":"2003","unstructured":"Brown D.; Superti-Furga G.; Rediscovering the sweet spot in drug discovery. Drug Discov Today 2003,8(23),1067-1077","journal-title":"Drug Discov Today"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"753","DOI":"10.4155\/fmc.15.21","volume":"7","author":"Ferreira L.G.","year":"2015","unstructured":"Ferreira L.G.; Oliva G.; Andricopulo A.D.; Target-based molecular modeling strategies for schistosomiasis drug discovery. Future Med Chem 2015,7(6),753-764","journal-title":"Future Med Chem"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.1016\/S1473-3099(16)30475-3","volume":"17","author":"Mutapi F.","year":"2017","unstructured":"Mutapi F.; Maizels R.; Fenwick A.; Woolhouse M.; Human schistosomiasis in the post mass drug administration era. Lancet Infect Dis 2017,17(2),e42-e48","journal-title":"Lancet Infect Dis"},{"key":"ref=95","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000478","volume":"3","author":"Abdulla M-H.","year":"2009","unstructured":"Abdulla M-H.; Ruelas D.S.; Wolff B.; Drug discovery for schistosomiasis: hit and lead compounds identified in a library of known drugs by medium-throughput phenotypic screening. PLoS Negl Trop Dis 2009,3(7)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=96","first-page":"105","volume":"30","author":"Tavares N.C.","year":"2016","unstructured":"Tavares N.C.; de Aguiar P.H.N.; Gava S.G.; Oliveira G.; Mour\u00e3o M.M.; Schistosomiasis: setting routes for drug discovery. Special Topics Drug Discov 2016,30,105","journal-title":"Special Topics Drug Discov"},{"key":"ref=97","author":"dos Santos Carvalho O","year":"2008","unstructured":"dos Santos Carvalho O; Coelho PMZ; Lenzi HL; Schistosoma mansoni","journal-title":"SciELOEditora FIOCRUZ"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/nchembio.2007.17","volume":"3","author":"Inglese J.","year":"2007","unstructured":"Inglese J.; Johnson R.L.; Simeonov A.; High-throughput screening assays for the identification of chemical probes. Nat Chem Biol 2007,3(8),466-479","journal-title":"Nat Chem Biol"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/nchembio.534","volume":"7","author":"Lemieux G.A.","year":"2011","unstructured":"Lemieux G.A.; Liu J.; Mayer N.; Bainton R.J.; Ashrafi K.; Werb Z.; A whole-organism screen identifies new regulators of fat storage. Nat Chem Biol 2011,7(4),206-213","journal-title":"Nat Chem Biol"},{"key":"ref=100","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000759","volume":"4","author":"Peak E.","year":"2010","unstructured":"Peak E.; Chalmers I.W.; Hoffmann K.F.; Development and validation of a quantitative, high-throughput, fluorescent-based bioassay to detect schistosoma viability. PLoS Negl Trop Dis 2010,4(7)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"608","DOI":"10.4269\/ajtmh.2004.71.608","volume":"71","author":"Kotze A.C.","year":"2004","unstructured":"Kotze A.C.; Clifford S.; O\u2019Grady J.; Behnke J.M.; McCarthy J.S.; An in vitro larval motility assay to determine anthelmintic sensitivity for human hookworm and Strongyloides species. Am J Trop Med Hyg 2004,71(5),608-616","journal-title":"Am J Trop Med Hyg"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ijpddr.2015.07.002","volume":"5","author":"Rinaldi G.","year":"2015","unstructured":"Rinaldi G.; Loukas A.; Brindley P.J.; Irelan J.T.; Smout M.J.; Viability of developmental stages of Schistosoma mansoni quantified with xCELLigence worm real-time motility assay (xWORM). Int J Parasitol Drugs Drug Resist 2015,5(3),141-148","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"ref=103","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001494","volume":"6","author":"Marcellino C.","year":"2012","unstructured":"Marcellino C.; Gut J.; Lim K.C.; Singh R.; McKerrow J.; Sakanari J.; WormAssay: a novel computer application for whole-plate motion-based screening of macroscopic parasites. PLoS Negl Trop Dis 2012,6(1)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/nature08160","volume":"460","author":"Berriman M.","year":"2009","unstructured":"Berriman M.; Haas B.J.; LoVerde P.T.; The genome of the blood fluke Schistosoma mansoni. Nature 2009,460(7253),352-358","journal-title":"Nature"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/ncomms1001","volume":"1","author":"Herranz D.","year":"2010","unstructured":"Herranz D.; Mu\u00f1oz-Martin M.; Ca\u00f1amero M.; Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer. Nat Commun 2010,1(1),3","journal-title":"Nat Commun"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nature08981","volume":"464","author":"Kaeberlein M.","year":"2010","unstructured":"Kaeberlein M.; Lessons on longevity from budding yeast. Nature 2010,464(7288),513-519","journal-title":"Nature"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1016\/j.ddmod.2012.01.004","volume":"9","author":"Curtin N.J.","year":"2012","unstructured":"Curtin N.J.; Poly (ADP-ribose) polymerase (PARP) and PARP inhibitors. Drug Discov Today Dis Models 2012,9(2),e51-e58","journal-title":"Drug Discov Today Dis Models"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/ph11010015","volume":"11","author":"Gouveia M.J.","year":"2018","unstructured":"Gouveia M.J.; Brindley P.J.; G\u00e4rtner F.; Costa J.M.C.D.; Vale N.; Drug repurposing for schistosomiasis: combinations of drugs or biomolecules. Pharmaceuticals (Basel) 2018,11(1),15","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref=109","first-page":"2789","volume":"57","author":"Maenza J.","year":"1998","unstructured":"Maenza J.; Flexner C.; Combination antiretroviral therapy for HIV infection. Am Fam Physician 1998,57(11),2789-2798","journal-title":"Am Fam Physician"},{"key":"ref=110","author":"King C.H.","year":"2011","unstructured":"King C.H.;  Schistosomiasis: challenges and opportunitiesThe causes and impacts of neglected tropical and zoonotic diseases: Opportunities for integrated intervention strategies 2011","journal-title":"Schistosomiasis: challenges and opportunitiesThe causes and impacts of neglected tropical and zoonotic diseases: Opportunities for integrated intervention strategies"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s00436-009-1371-7","volume":"104","author":"Abdul-Ghani R.","year":"2009","unstructured":"Abdul-Ghani R.; Loutfy N.; el-Sahn A.; Hassan A.; Current chemotherapy arsenal for schistosomiasis mansoni: alternatives and challenges. Parasitol Res 2009,104(5),955-965","journal-title":"Parasitol Res"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0035-9203(83)90008-1","volume":"77","author":"Shaw J.R.","year":"1983","unstructured":"Shaw J.R.; Brammer K.W.; The treatment of experimental schistosomiasis with a combination of oxamniquine and praziquantel. Trans R Soc Trop Med Hyg 1983,77(1),39-40","journal-title":"Trans R Soc Trop Med Hyg"}],"container-title":["Current Drug Discovery Technologies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570163817666200806170654","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/184608\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570163817666200806170654","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T20:31:55Z","timestamp":1656189115000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/184608\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":112,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1570163817666200806170654","relation":{},"ISSN":["1570-1638"],"issn-type":[{"type":"print","value":"1570-1638"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-04-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-06","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}